Consistently, AXIN2 knockout clones exhibited elevated β‐catenin protein levels, demonstrating that loss of AXIN2 impairs degradation of β‐catenin in APC mutant colorectal cancer cells (Fig. 1B,C). This evidence concerns the gene APC and colorectal cancer.